A number of approaches have shown that reduction in Rad51 levels via antisense oligonucleotides (Taki et al, 1996; Ohnishi et al, 1998), ribozymes (Collis et al, 2001) or drugs (Russell et al, 2003) increased the radiation sensitivity of tumour cell lines. Here, RAD51 is linked to neoplasm.